Search
InsiderInsights.com

Shallcross Steven A (1263501)

Shallcross Steven A has been a registered insider at 3 firms since 2006. As Chief Financial Officer at Cytomedix, Inc, Shallcross Steven A last made a transaction on 8/26/2014. As Chief Executive Officer at Adeona Pharmaceuticals, Inc, Shallcross Steven A last made a transaction on 6/7/2023. As Chief Financial Officer at Vanda Pharmaceuticals Inc., Shallcross Steven A last made a transaction on 11/27/2007.

CYTOMEDIX INC (GTF, AURX, NUOT, CMXI)

Titles: CFO

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 0% -85% -85% 1 1 Year 2 0% -- -- --
2 0% -35% -35% 3 9 Month 2 0% -- -- --
2 0% -28% -28% 1 6 Month 2 0% -- -- --
2 0% -24% -24% 0 3 Month 2 0% -- -- --
2 100% 8% 8% 5 1 Month 2 0% -- -- --
2 0% -5% -5% 6 1 Week 2 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/8/2023 05:49 PM EST Latest Transaction Date: 8/26/2014
Average days between Transaction and Entered Dates: 1

Synthetic Biologics, Inc. (AEN, SYN, TOVX)

Titles: CEO,CFO,DIR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 50% -6% -6% 90 1 Year 2 0% -- -- --
2 0% -28% -28% 26 9 Month 2 0% -- -- --
2 50% 2% 2% 32 6 Month 2 0% -- -- --
7 43% -11% -24% 61 3 Month 7 0% -- -- --
7 71% 11% 8% 102 1 Month 7 0% -- -- --
7 71% 8% 4% 45 1 Week 7 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 6/8/2023 05:49 PM EST Latest Transaction Date: 6/7/2023
Average days between Transaction and Entered Dates: 2

Vanda Pharmaceuticals Inc. (VNDA)

Titles: VP,CFO,TR

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 0% -81% -- -- 1 Year 1 0% -- -- --
1 0% -34% -- -- 9 Month 1 0% -- -- --
1 0% -26% -- -- 6 Month 1 0% -- -- --
1 0% -24% -- -- 3 Month 1 0% -- -- --
1 100% 1% -- -- 1 Month 1 0% -- -- --
1 100% 14% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
12 100% -84% -83% 28 1 Year 12 0% -- -- --
12 100% -69% -72% 53 9 Month 12 0% -- -- --
12 100% -51% -54% 68 6 Month 12 0% -- -- --
12 100% -30% -26% 68 3 Month 12 0% -- -- --
12 67% -10% -4% 68 1 Month 12 0% -- -- --
12 75% -3% -3% 27 1 Week 12 0% -- -- --
Scorecards Updated 6/8/2023 05:49 PM EST Latest Transaction Date: 11/27/2007
Average days between Transaction and Entered Dates:
© 2024 InsiderInsights.com